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Abstract 
Unbalanced 1q translocations leading to complete 
or partial trisomies of the long arm of chromosome 
1 have been widely reported in both lymphoid and 
myeloid neoplasms. Chromosomal translocations 
between the long arm of chromosome 1 and the 
acrocentric chromosome 15 are mostly secondary  
events representing clonal evolution. 
Keywords 
Gain of 1q, unbalanced translocations, acrocentric 
chromosomes, gene overexpression. 
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Figure 2.  Fluorescence in situ hybridization with LSI 1p36/1q25 probe (Vysis, Abott Molecular, US) showing the extra green 
signal of 1q25 on der(15) chromosome (A). Hybridization with LSI PML/RARA probe revealing the red  signal for PML located on 
der(15) chromosome (B).  
 
Clinics and pathology 
Disease 
Chronic and acute myeloid malignancies, B-cell 
acute lymphoblastic leukemia (ALL), multiple 
myeloma (MM) and lymphomas. 
Phenotype/cell stem origin 
Etiology 
Patients with der(15)t(1;15)(q11;p11-13) were 
diagnosed mainly with  myeloid malignancies (10 
patients): 1 polycythemia vera (PV) (Sanford et al., 
2015), 5 myelodysplastic syndromes (MDS) 
(Mecucci et al., 1986; Mascarello et al., 1989; 
Jotterand-Bellomo et al., 1990; Najfeld et al., 1995) 
and 5 patients were diagnosed with acute myeloid 
leukemia (AML) (Andrieux et al., 2006; Farag et 
al., 2006; Poppe et al., 2006; Liu et al., 2007; 
Manola et al., 2008).  In addition, there was 1 
female with non neoplastic disorder (aplastic 
anemia) (Kim et al., 2010). Acute lymphoblastic 
leukemia was diagnosed in 7 (Raimondi et al., 
1990; Heerema et al., 1999;  Rafi et al., 2000; 
Boomer et al., 2001;  Wan et al., 2004; Wetzler et 
al., 2004;  Coyaud et al., 2010) and multiple 
myeloma in 3 (Calasanz et al., 1997; Rajkumar et 
al., 1999; Smadja et., al 2001). 7 patients has 
various B-cell lymphomas: 1 mature B-cell 
neoplasm (MBCL), 3 follicular lymphoma (FL) 
(Horsman et al., 2001; Le Baccon et al., 2001; 
Narayan et al., 2013), 2 diffuse large B-cell 
lymphoma (DLBL) (Fan & Rizkalla., 2003; 
Havelange et al., 2013) and 1 mantle cell  
 
 
lymphoma (MCL) (Fan  Rizkalla., 2003) (Table 1).  
Patients with der(15)t(1;15)(q21-25;p10-13)   
were diagnosed with lymphoproliferative 
malignancies (10 patients), among them acute 
lymphoblastic leukemia in 3 (Strefford et al., 2007; 
Schmiegelow et al., 2012; Safavi et al., 2015) and 
various, mainly B-cell lymphomas in 9: 1 adult T-
cell lymphoma/leukemia (HTLV-1+) (ATLL) 
(Kamada et al., 1992), 4 diffuse large B-cell 
lymphomas (DLBCL) (Sandlund et al., 1994; Miura 
et al., 1996; Aamot et al., 2005; Zhang et al., 2009), 
1 lymphoplasmacytic lymphoma (LPL) (Khokhar et 
al., 1995), 1 Burkitt lymphoma/leukemia (BL) 
(Silva et al., 2002) and 2 follicular lymphomas (FL) 
(Lestou et al., 2003; Keller et al., 2006).  Sporadic 
cases of other malignancies: 1 acute myeloid 
leukemia (AML) (Olsson et al., 2016) and 1 
multiple myeloma (MM) (Nakano et al., 2005).  
Epidemiology 
The centromeric 1q11-12 translocation was 
reported at least in 29 patients (10 males and 19 
females aged 0 to 81 years; median 47 years); 
among them there was 1 infant and 3 pediatric 
patients aged 13 to 15 years. Patients with 1q21-25 
were less frequent and have been reported in 9 
males and 5 females aged 6 to 79 years (median 22 
years), 5 of them were children aged 6 to 11 years 
(4 males and 1 female). 
Prognosis 
In patients with complex karyotypes the appearance 
of the abnormality is associated with advanced 
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Table 2.  Clinical and karyotypic data of patients with der(15)t(1;15)(q21-25;p10-13).  
 
AbbreviationsTable 1:  M, male; F, female; AA, Aplastic anemia, RARS, Refractory anemia with ringed  sideroblasts; RA, 
Refractory anemia; RAEB, Refractory anemia with excess of  blasts; PV, Polycythemia vera; AML-M5, Acute monoblastic 
leukemia with  differentiation; AML, Acute myeloid leukemia; AML-M2, Acute myeloblastic  leukemia with maturation; AML-M1, 
Acute myeloblastic leukemia without  maturation; ALL,  Acute lymphoblastic  leukemia; MM, Multiple myeloma; MBCN, Mature B-
cell neoplasm; LN, lymph node, FL,  Follicular lymphoma, MCL, Mantle cell  lymphoma; DLBCL, Diffuse large B-cell lymphoma. 
1. Kim et al., 2010; 2-3. Mecucci et al., 1986; 4. Mascarello et al., 1989; 5.  Jotterand-Bellomo et al., 1990; 6. Najfeld et al., 1995; 
7. Sanford et al.,  2015 ; 8. Andrieux et al., 2006; 9. Farag et al., 2006; 10. Poppe et al., 2006;  11. Liu et al., 2007; 12. Manola et 
al., 2008; 13. Raimondi et al., 1990; 14.  Heerema et al., 1999; 15. Rafi et al., 2000; 16. Boomer et al., 2001; 17. Wan  et al., 
2004; 18. Wetzler et al., 2004; 19. Coyaud et al., 2010; 20. Calasanz  et al., 1997; 21. Rajkumar et al., 1999; 22. Smadja et al., 
2001; 23. Kobayashi  et al., 1993; 24. Horsman et al., 2001; 25. Le Baccon et al., 2001; 26-27. Fan  & Rizkalla 2003; 28. 
Havelange et al., 2013; 29. Narayan et al., 2013. 
Abbreviations Table 2:  M, male; F, female; AML, acute myeloid leukemia; ALL, acute lymphoblastic leukemia; MM, multiple 
myeloma;. ATLL, adult T-cell lymphoma/leukemia; DLBCL  diffuse large B-cell lymphoma; LPL, lymphoplasmacytic lymphoma; 
LN, lymph node;  BL, Burkitt lymphoma/leukemia; FL, follicular lymphoma.  
1.  Olsson et al., 2016; 2. Strefford et al., 2007; 3. Schmiegelow et al., 2012; 4.  Safavi et al., 2015; 5. Nakano et al., 2005; 6. 
Kamada et al., 1992; 7.  Sandlund et al., 1994; 8. Khokhar et al., 1995; 9. Miura et al., 1996; 10.  Silva et al., 2002; 11. Lestou et 
al., 2003; 12. Aamot et al., 2005; 13. Keller  et al., 2006; 14. Zhang et al., 2009. 
 
Cytogenetics 
To exclude the presence of dic(1;15)(p10-11;p10-
11) or dic(1;15)(q10 11;q10-11) fluorescence in situ 
hybridization with centromere-specific probes for 
both chromosomes is recommended. 
Cytogenetics morphological 
der(15)t(1;15)(q11-2;p11-13)  was found as a sole 
anomaly in 2 MDS (Mecucci et al., 1986; Jotterand-
Bellomo et al., 1990), 1 AML (Farag et al., 2006) 
and in the aplastic anemia patient (Kim et al., 
2010). Found in association with del(5)(q14q32) 
and del(20)(q11) in 1 MDS (Mecucci et al., 1986) 
and +8 and del(20)(q13) in PV (Sanford et al., 
2015). Associated with 
der(19)t(1;19)(q23;p13)/t(1;19)(q23;p13) in 4 out 
of 7 ALL patients (Raimondi et al., 1990; Heerema 
et al., 1999; Boomer et al., 2001; Coyaud et al., 
2010), t(9;22)(q34;q11) in 2 (Wan et al., 2004; 
Wetzler et al., 2004) and t(8;22)(q24;q11) in 1 (Rafi 
et al 2000). Found with t(11;14)(q13;q32) in 2 out 
of 3 MM (Calasanz et al., 1997; Smadja et al., 
2001) and 1 patient with MCL (Fan & Rizkalla 
2003), 14q32/ t(14;18)(q32;q21) in 4 lymphomas 
(Kobayashi et al., 1993; Horsman et al., 2001; Le 
Baccon et al., 2001; Fan  Rizkalla 2003) and highly 
complex karyotypes in the remaining patients.  
In the group of patients with 1q21-25 
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(Strefford et al., 2007) and 1 MM (Nakano et al., 
2005) and found with 
t(1;19)(q23;p13)/der(19)t(1;19)(q23;p13) in the 
remaining 2 ALL patients (Schmiegelow et al., 
2012; Safavi et al., 2015); found as a part of highly 
complex karyotypes in lymphoma patients. 




Unbalanced 1q translocations with an acrocentric 
recipient chromosome 15 result in 1q trisomy.  The 
main consequence of these rearrangements is 
genomic imbalance resulting from the presence of 
an extra copy of the long arm of chromosome 1, 
leading to overexpression of several genes, likely 
implicated in neoplastic processes by a gene dosage 
effect. They presumably occur as a secondary 
aberration in addition to well-known primary 
abnormalities, therefore representing clonal 
evolution preceding or accompanying disease 
progression. 
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